220 related articles for article (PubMed ID: 31994701)
1. Blocking Entry of Hepatitis B and D Viruses to Hepatocytes as a Novel Immunotherapy for Treating Chronic Infections.
Maravelia P; Frelin L; Ni Y; Caro Pérez N; Ahlén G; Jagya N; Verch G; Verhoye L; Pater L; Johansson M; Pasetto A; Meuleman P; Urban S; Sällberg M
J Infect Dis; 2021 Jan; 223(1):128-138. PubMed ID: 31994701
[TBL] [Abstract][Full Text] [Related]
2. Novel prime-boost immune-based therapy inhibiting both hepatitis B and D virus infections.
Burm R; Maravelia P; Ahlen G; Ciesek S; Caro Perez N; Pasetto A; Urban S; Van Houtte F; Verhoye L; Wedemeyer H; Johansson M; Frelin L; Sällberg M; Meuleman P
Gut; 2023 Jun; 72(6):1186-1195. PubMed ID: 35977815
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis Delta co-infection in humanized mice leads to pronounced induction of innate immune responses in comparison to HBV mono-infection.
Giersch K; Allweiss L; Volz T; Helbig M; Bierwolf J; Lohse AW; Pollok JM; Petersen J; Dandri M; Lütgehetmann M
J Hepatol; 2015 Aug; 63(2):346-53. PubMed ID: 25795587
[TBL] [Abstract][Full Text] [Related]
4. Strategies to inhibit entry of HBV and HDV into hepatocytes.
Urban S; Bartenschlager R; Kubitz R; Zoulim F
Gastroenterology; 2014 Jul; 147(1):48-64. PubMed ID: 24768844
[TBL] [Abstract][Full Text] [Related]
5. Support of the infectivity of hepatitis delta virus particles by the envelope proteins of different genotypes of hepatitis B virus.
Freitas N; Abe K; Cunha C; Menne S; Gudima SO
J Virol; 2014 Jun; 88(11):6255-67. PubMed ID: 24648462
[TBL] [Abstract][Full Text] [Related]
6. Humanized chimeric uPA mouse model for the study of hepatitis B and D virus interactions and preclinical drug evaluation.
Lütgehetmann M; Mancke LV; Volz T; Helbig M; Allweiss L; Bornscheuer T; Pollok JM; Lohse AW; Petersen J; Urban S; Dandri M
Hepatology; 2012 Mar; 55(3):685-94. PubMed ID: 22031488
[TBL] [Abstract][Full Text] [Related]
7. Designing a therapeutic hepatitis B vaccine to circumvent immune tolerance.
Whitacre DC; Peters CJ; Sureau C; Nio K; Li F; Su L; Jones JE; Isogawa M; Sallberg M; Frelin L; Peterson DL; Milich DR
Hum Vaccin Immunother; 2020; 16(2):251-268. PubMed ID: 31809638
[TBL] [Abstract][Full Text] [Related]
8. N-terminal myristoylation-dependent masking of neutralizing epitopes in the preS1 attachment site of hepatitis B virus.
Bremer CM; Sominskaya I; Skrastina D; Pumpens P; El Wahed AA; Beutling U; Frank R; Fritz HJ; Hunsmann G; Gerlich WH; Glebe D
J Hepatol; 2011 Jul; 55(1):29-37. PubMed ID: 21145866
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis Delta Virus Acts as an Immunogenic Adjuvant in Hepatitis B Virus-Infected Hepatocytes.
Tham CYL; Kah J; Tan AT; Volz T; Chia A; Giersch K; Ladiges Y; Loglio A; Borghi M; Sureau C; Lampertico P; Lütgehetmann M; Dandri M; Bertoletti A
Cell Rep Med; 2020 Jul; 1(4):100060. PubMed ID: 33205065
[TBL] [Abstract][Full Text] [Related]
10. Efficient Inhibition of Hepatitis B Virus Infection by a preS1-binding Peptide.
Ye X; Zhou M; He Y; Wan Y; Bai W; Tao S; Ren Y; Zhang X; Xu J; Liu J; Zhang J; Hu K; Xie Y
Sci Rep; 2016 Jul; 6():29391. PubMed ID: 27384014
[TBL] [Abstract][Full Text] [Related]
11. Persistent hepatitis D virus mono-infection in humanized mice is efficiently converted by hepatitis B virus to a productive co-infection.
Giersch K; Helbig M; Volz T; Allweiss L; Mancke LV; Lohse AW; Polywka S; Pollok JM; Petersen J; Taylor J; Dandri M; Lütgehetmann M
J Hepatol; 2014 Mar; 60(3):538-44. PubMed ID: 24280293
[TBL] [Abstract][Full Text] [Related]
12. Identification of Novel HBV/HDV Entry Inhibitors by Pharmacophore- and QSAR-Guided Virtual Screening.
Kirstgen M; Müller SF; Lowjaga KAAT; Goldmann N; Lehmann F; Alakurtti S; Yli-Kauhaluoma J; Baringhaus KH; Krieg R; Glebe D; Geyer J
Viruses; 2021 Jul; 13(8):. PubMed ID: 34452354
[TBL] [Abstract][Full Text] [Related]
13. Recombinant hepatitis B core antigen carrying preS1 epitopes induce immune response against chronic HBV infection.
Chen X; Li M; Le X; Ma W; Zhou B
Vaccine; 2004 Jan; 22(3-4):439-46. PubMed ID: 14670326
[TBL] [Abstract][Full Text] [Related]
14. Mouse models of hepatitis B and delta virus infection.
Dandri M; Lütgehetmann M
J Immunol Methods; 2014 Aug; 410():39-49. PubMed ID: 24631647
[TBL] [Abstract][Full Text] [Related]
15. Applications of human hepatitis B virus preS domain in bio- and nanotechnology.
Toita R; Kawano T; Kang JH; Murata M
World J Gastroenterol; 2015 Jun; 21(24):7400-11. PubMed ID: 26139986
[TBL] [Abstract][Full Text] [Related]
16. Ubiquitinated Hepatitis D Antigen-Loaded Microvesicles Induce a Potent Specific Cellular Immune Response to Inhibit HDV Replication in Vivo.
Yao T; Lv M; Ma S; Chen J; Zhang Y; Yu Y; Zang G; Chen X
Microbiol Spectr; 2021 Dec; 9(3):e0102421. PubMed ID: 34908456
[TBL] [Abstract][Full Text] [Related]
17. Use of FDA approved therapeutics with hNTCP metabolic inhibitory properties to impair the HDV lifecycle.
Blanchet M; Sureau C; Labonté P
Antiviral Res; 2014 Jun; 106():111-5. PubMed ID: 24717262
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of Virus Antigen Expression Increases Therapeutic Vaccine Efficacy in High-Titer Hepatitis B Virus Carrier Mice.
Michler T; Kosinska AD; Festag J; Bunse T; Su J; Ringelhan M; Imhof H; Grimm D; Steiger K; Mogler C; Heikenwalder M; Michel ML; Guzman CA; Milstein S; Sepp-Lorenzino L; Knolle P; Protzer U
Gastroenterology; 2020 May; 158(6):1762-1775.e9. PubMed ID: 32001321
[TBL] [Abstract][Full Text] [Related]
19. A potent human neutralizing antibody Fc-dependently reduces established HBV infections.
Li D; He W; Liu X; Zheng S; Qi Y; Li H; Mao F; Liu J; Sun Y; Pan L; Du K; Ye K; Li W; Sui J
Elife; 2017 Sep; 6():. PubMed ID: 28949917
[TBL] [Abstract][Full Text] [Related]
20. A Novel Tricyclic Polyketide, Vanitaracin A, Specifically Inhibits the Entry of Hepatitis B and D Viruses by Targeting Sodium Taurocholate Cotransporting Polypeptide.
Kaneko M; Watashi K; Kamisuki S; Matsunaga H; Iwamoto M; Kawai F; Ohashi H; Tsukuda S; Shimura S; Suzuki R; Aizaki H; Sugiyama M; Park SY; Ito T; Ohtani N; Sugawara F; Tanaka Y; Mizokami M; Sureau C; Wakita T
J Virol; 2015 Dec; 89(23):11945-53. PubMed ID: 26378168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
